Neuroprotective effects of farnesol on motor and cognitive impairment against 3-nitropropionic acid-induced Huntington's disease.
- Published in:
- Thai Journal of Pharmaceutical Sciences, 2021, v. 45, n. 1, p. 16
- By:
- Publication type:
- Article
Works matching AU Rymbai, Emdormi
Results: 12
1
2
Phosphodiesterase-4 Inhibition in Parkinson's Disease: Molecular Insights and Therapeutic Potential.
- Published in:
- Cellular & Molecular Neurobiology, 2023, v. 43, n. 6, p. 2713, doi. 10.1007/s10571-023-01349-1
- By:
- Publication type:
- Article
3
Temporal Unpredictability and Probabilistic Uncertainty Induced Anxiety in the Times of COVID-19 Pandemic.
- Published in:
- Indian Journal of Pharmaceutical Education & Research, 2022, v. 56, n. 2, p. 321, doi. 10.5530/ijper.56.2.52
- By:
- Publication type:
- Article
4
Using Link and Major System of Memory to Memorise, Remember and Recall Pharmaceutical Sciences Better.
- Published in:
- Indian Journal of Pharmaceutical Education & Research, 2020, v. 54, p. 438, doi. 10.5530/ijper.54.3s.142
- By:
- Publication type:
- Article
5
Ligandrol Ameliorates High-Fat Diet– and Streptozotocin-Induced Type 2 Diabetes Mellitus and Prevents Pancreatic Islets Degeneration.
- Published in:
- Assay & Drug Development Technologies, 2024, v. 22, n. 8, p. 397, doi. 10.1089/adt.2024.029
- By:
- Publication type:
- Article
6
Molecular insights into the potential effects of selective estrogen receptor β agonists in Alzheimer's and Parkinson's diseases.
- Published in:
- Cell Biochemistry & Function, 2024, v. 42, n. 3, p. 1, doi. 10.1002/cbf.4014
- By:
- Publication type:
- Article
7
Roflumilast-loaded nanostructured lipid carriers attenuate oxidative stress and neuroinflammation in Parkinson's disease model.
- Published in:
- Journal of Drug Targeting, 2025, v. 33, n. 1, p. 127, doi. 10.1080/1061186X.2024.2408724
- By:
- Publication type:
- Article
8
Role of estrogen receptors in cancer: a special emphasis on the therapeutic potential of estrogen receptor ß.
- Published in:
- Pharmaceutical Sciences Asia, 2022, v. 49, n. 5, p. 408, doi. 10.29090/psa.2022.05.22.042
- By:
- Publication type:
- Article
9
Gene network analysis combined with preclinical studies to identify and elucidate the mechanism of action of novel irreversible Keap1 inhibitor for Parkinson's disease.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 3, p. 2081, doi. 10.1007/s11030-024-10965-y
- By:
- Publication type:
- Article
10
The identification of c-Abl inhibitors as potential agents for Parkinson's disease: a preliminary in silico approach.
- Published in:
- Molecular Diversity, 2024, v. 28, n. 6, p. 4051, doi. 10.1007/s11030-023-10796-3
- By:
- Publication type:
- Article
11
Side effects based network construction and drug repositioning of ropinirole as a potential molecule for Alzheimer's disease: an in-silico, in-vitro, and in-vivo study.
- Published in:
- Journal of Biomolecular Structure & Dynamics, 2024, v. 42, n. 20, p. 10785, doi. 10.1080/07391102.2023.2258968
- By:
- Publication type:
- Article
12
Importance of Fibrosis in the Pathogenesis of Uterine Leiomyoma and the Promising Anti-fibrotic Effects of Dipeptidyl Peptidase-4 and Fibroblast Activation Protein Inhibitors in the Treatment of Uterine Leiomyoma.
- Published in:
- Reproductive Sciences, 2023, v. 30, n. 5, p. 1383, doi. 10.1007/s43032-022-01064-0
- By:
- Publication type:
- Article